Global Regulatory Differences for Gene‐ and Cell‐Based Therapies: Consequences and Implications for Patient Access and Therapeutic Innovation
Delphi G.M. Coppens; Marie L. De Bruin; Hubert G.M. Leufkens; Jarno Hoekman
Author Information: Utrecht/WHO Collaborating Centre for Pharmaceutical Policy and Regulation, Utrecht Institute for Pharmaceutical Sciences
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.